Bhagiradha Chemicals & Industries Ltd Upgraded to Sell on Technical Improvements

Technical Trend Shifts to Sideways but Remain Mixed

The primary catalyst for the recent rating adjustment lies in the technical analysis of Bhagiradha Chemicals’ stock. The technical grade has improved from mildly bearish to sideways, signalling a pause in the previous downtrend. Weekly indicators such as the MACD and KST have turned mildly bullish, while the Dow Theory also reflects a mildly bullish stance on both weekly and monthly timeframes. Additionally, the On-Balance Volume (OBV) indicator shows bullish momentum on weekly and monthly charts, suggesting accumulation by investors.

However, this optimism is tempered by monthly technicals that remain bearish, including the MACD and KST, and daily moving averages that continue to show mild bearishness. Bollinger Bands present a mixed picture with weekly readings bullish but monthly readings mildly bearish. The Relative Strength Index (RSI) offers no clear signal on either weekly or monthly charts. This blend of signals indicates that while short-term technical momentum has improved, longer-term trends remain uncertain.

The stock price has responded positively in the short term, rising 6.43% on the latest trading day to ₹250.05 from a previous close of ₹234.95. The 52-week range remains wide, with a high of ₹329.95 and a low of ₹183.30, reflecting significant volatility over the past year.

Financial Trend Remains Weak with Consecutive Negative Results

Despite some technical stabilisation, Bhagiradha Chemicals’ financial performance continues to disappoint. The company has reported negative results for five consecutive quarters, with the latest quarter (Q3 FY25-26) reflecting a decline in key metrics. Net sales have grown at a modest compound annual growth rate (CAGR) of 14.52% over the past five years, but operating profit growth has been negligible at just 1.97% annually.

Profitability has deteriorated sharply, with profits falling by 39.8% over the past year. The return on capital employed (ROCE) is alarmingly low at 2.8% for the half-year period, and the company’s interest expense has surged by 80.59% to ₹10.42 crores over nine months. The debt-equity ratio, while still moderate at 0.27 times, is the highest recorded in recent periods, signalling increased leverage risk.

These financial weaknesses have contributed to the downgrade in the company’s Mojo Grade from Strong Sell to Sell, with the overall Mojo Score now at 32.0. The company remains classified as a small-cap stock within the Pesticides & Agrochemicals sector, which has seen mixed performance in recent months.

Valuation Concerns Amid Expensive Multiples

Bhagiradha Chemicals is currently trading at a premium valuation relative to its peers. The enterprise value to capital employed ratio stands at 4.0, which is considered expensive given the company’s low ROCE and subdued earnings growth. This valuation premium is difficult to justify in light of the company’s weak profitability and negative earnings trajectory.

Moreover, the stock’s underperformance relative to broader market indices adds to valuation concerns. Over the past year, Bhagiradha Chemicals has generated a negative return of 9.86%, while the BSE500 index has delivered a positive 4.28% return. This underperformance is further highlighted by the stock’s year-to-date return of 13.61%, which, although positive, trails the Sensex’s decline of 6.98% over the same period.

Domestic mutual funds hold no stake in the company, signalling a lack of institutional confidence. Given their capacity for in-depth research and on-the-ground analysis, this absence suggests that mutual funds either find the current price unattractive or harbour concerns about the company’s business prospects.

Quality Parameters Reflect Struggles Despite Debt Servicing Ability

From a quality perspective, Bhagiradha Chemicals exhibits mixed signals. The company’s ability to service debt remains relatively strong, with a Debt to EBITDA ratio of 4.80 times, indicating manageable leverage in the context of earnings before interest, taxes, depreciation, and amortisation. However, the low ROCE and persistent negative quarterly results undermine the overall quality assessment.

The company’s long-term growth prospects appear limited, with sluggish sales and operating profit growth over the last five years. This stagnation, combined with rising interest costs and a deteriorating profitability profile, weighs heavily on the quality rating and investor confidence.

Stock Performance and Market Comparison

Bhagiradha Chemicals’ stock has delivered mixed returns over various time horizons. While the 5-year return of 423.50% and an impressive 10-year return of 1952.96% significantly outperform the Sensex’s 66.17% and 206.31% respectively, recent performance has been lacklustre. The 1-year return of -9.86% contrasts sharply with the Sensex’s near-flat return of -0.17%, and the 1-month return of 38.80% outpaces the Sensex’s 6.36%, indicating short-term volatility and potential recovery attempts.

These divergent returns highlight the stock’s cyclical nature and the challenges it faces in sustaining long-term growth momentum amid sectoral and macroeconomic pressures.

Outlook and Investor Considerations

In summary, Bhagiradha Chemicals & Industries Ltd’s recent rating downgrade to Sell reflects a nuanced assessment of its current standing. The technical indicators suggest a stabilisation in price action, with some short-term bullish signals emerging. However, these are overshadowed by weak financial trends, including consecutive quarterly losses, low profitability, and rising interest expenses.

The company’s valuation remains stretched relative to its earnings and capital efficiency, raising questions about the sustainability of its current price levels. The absence of domestic mutual fund holdings further underscores institutional scepticism.

Investors should weigh these factors carefully, considering the company’s long-term growth challenges and sector dynamics. While the stock has demonstrated strong returns over extended periods, recent underperformance and financial headwinds warrant caution.

For those seeking exposure to the Pesticides & Agrochemicals sector, alternative stocks with stronger financial metrics and more favourable valuations may offer better risk-adjusted returns.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today